Not Signed In - First Patients Undergo Surgery In Northwest Biotherapeutics' Phase II Brain Cancer Trial
Wed, 14 Feb 2007 08:00 AM EST
... Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB), a biotechnology company focused on cancer immunotherapy, today announced that the first two patients in its pivotal Phase II clinical trial have undergone surgery for newly diagnosed Glioblastoma multiforme (GBM), which is the first step in the preparation of the Company's DCVax(R)-Brain treatment. [click link for full article] ...
Related Topics
- Clinical Trials
- Brain Cancer
- Brain Tumor
- Brain Aneurysm
- Pancreatic Cancer
- Cancer
- Cancers
- Prostate Cancer
- Lung Cancer
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Bladder Cancer
- Metastatic Cancer
- Kidney Cancer
- Esophageal Cancer
- Colon Cancer
- Childhood Cancers
- Liver Cancer
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Surgery
- Thyroid Cancer
email this page
print this page
bookmark this page
feedback on this page
